Tuesday, December 22, 2020 9:21:00 AM
Evofem Biosciences to Participate in Medicaid National Drug Rebate Program for Phexxi® Effective January 1, 2021
December 22 2020 - 07:00AM
PR Newswire (US)
Alert
Share On Facebook
SAN DIEGO, Dec. 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it has entered into an agreement with the U.S. Centers for Medicare and Medicaid Services (CMS) to participate in the Medicaid National Drug Rebate Program (NDRP), providing access to Phexxi® (lactic acid, citric acid and potassium bitartrate) for the Medicaid population effective January 1, 2021.
(PRNewsfoto/Evofem Biosciences, Inc.)
"Contraceptive choice should not be a luxury available to only some women. Every woman deserves to choose the method that is right for her individual health needs and unique circumstances," said Saundra Pelletier, Evofem's Chief Executive Officer. "We are proud to participate in the NDRP, ensuring that millions of women across the nation who rely on Medicaid for healthcare coverage have access to Phexxi for hormone free, on-demand contraception."
Medicaid provides health coverage to 69.8 million people in the United States, including approximately 25 million adult women2. Medicaid is administered by states, according to federal requirements, where each state can determine specific coverage for Phexxi. Per the terms of the NDRP, states must generally cover a manufacturer's drugs as of the mandatory effective date.
Recent EVFM News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 09/23/2024 08:48:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 09:04:02 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/21/2024 04:11:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 08:05:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 11:05:58 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:00:25 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 08:35:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 12:15:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 10:50:31 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:45:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:14:53 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:14:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 02:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:26:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 10:13:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:53:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:17:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:05:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 11:40:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:07:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 12:50:10 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM